Partnerships with External Companies for Prefectural Government Contracts and New Services

「Multiple initiatives, including AI for predicting the likelihood of undergoing health checkups and RWD × AI joint development, have progressed since the fiscal year ending March 2026.」

「For the data utilization services, the number of transacting companies and average transaction value are growing strongly as the sales and solution infrastructure is expanded. The company will sustain strong growth and further expand revenue by continuing to enhance the quality and volume of its database, collaborating with business partners, utilizing multiple types of RWD (real-world data) from a single dataset, and pursuing combinations of proprietary data and AI products.」

「In addition, demand from customers for the Group's solutions in its data utilization services remains strong. Revenue for the six-month interim consolidated period increased by 62.2% from the same period of the previous year, the six months from April to September 2024, and the company expects continued strong growth on a full-year basis for the fiscal year ending March 2026. The number of companies that transacted with the company during the most recent 12 months to the end of September 2025 was 69, including 34 pharmaceutical companies and other such companies, up steadily from 61 in the same period of the previous year, including 29 pharmaceutical companies and other such companies. Transaction value per customer also increased by 20% year on year.」

「In addition, demand from customers for the Group's solutions in its data utilization services remains strong. Revenue for the current consolidated fiscal year increased by 45% from the same period of the previous year, the nine-month period from July 2023 to March 2024, and the company expects continued strong growth from the next fiscal year onward.」

「For the newly launched data utilization services, the company will expand adoption by enhancing the quality and volume of its database, broaden the scope of value provided to pharmaceutical companies, academia and other customers through partnerships with other companies, and pursue further growth in revenue.」

「Under the new organizational structure, during the nine-month period ended in the third quarter of the current consolidated fiscal year, the Group actively pursued activities to launch the data utilization business in addition to sales activities for its existing data health-related services. Revenue from the data utilization business launched in collaboration with ＤｅＳＣヘルスケア株式会社 since the previous fiscal year was ¥692 million and is growing steadily.」

「Under the new organizational structure, during the six-month period ended in the second quarter of the current consolidated fiscal year, the Group actively pursued activities to launch the data utilization business in addition to sales activities for its existing data health-related services.」

「Through these business combinations, the company will strengthen collaboration within the DeNA Co.,Ltd. group, focusing on data health-related and data utilization businesses, and develop new core businesses.」

「The company is collaborating with ＤｅＳＣヘルスケア株式会社 on a data utilization business to promote the further use of medical information. Making ＤｅＳＣヘルスケア株式会社 a consolidated subsidiary will accelerate efforts in this new data utilization business.」

「In addition, as the government is expected to promote the National Health Insurance Health Improvement Support Program for prefectural governments, the Group will partner with companies that possess strengths not available within the Group, including DeNA Co.,Ltd., ＤｅＳＣヘルスケア株式会社 and WingArc1st Inc., to win new prefecture-level orders and acquire customers.」